AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
AAPL   321.85 (+1.23%)
MSFT   182.83 (-0.23%)
FB   231.91 (+3.03%)
GOOGL   1,434.87 (+0.09%)
AMZN   2,471.04 (+1.17%)
NVDA   352.25 (-0.78%)
CGC   16.48 (-5.12%)
TSLA   898.10 (+7.56%)
AMD   53.63 (-0.32%)
T   30.93 (+0.23%)
ACB   14.10 (+0.14%)
F   5.87 (+2.80%)
NFLX   425.92 (+1.47%)
BAC   24.61 (+2.03%)
BA   151.39 (+3.80%)
Log in

NASDAQ:MTFBMOTIF BIO PLC/S Stock Price, Forecast & News

$0.10
+0.10 (+2,000.00 %)
(As of 12/16/2019)
Add
Compare
Today's Range
$0.10
Now: $0.11
$0.12
50-Day Range
$0.11
MA: $0.11
$0.11
52-Week Range
$0.08
Now: $0.11
$11.50
Volume867,698 shs
Average VolumeN/A
Market Capitalization$1.56 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Motif Bio plc, a clinical stage biopharmaceutical company, develops and commercializes pharmaceutical formulations in the United States. The company develops novel antibiotics for the treatment of serious and life-threatening infections caused by multi-drug resistant bacteria. Its lead product candidate is iclaprim, a novel antibiotic that is in Phase III clinical trials to treat bacterial infections, such as acute bacterial skin and skin structure infections, and hospital-acquired bacterial pneumonia caused by methicillin-resistant staphylococcus aureus, as well as to treat lung infections caused by Staphylococcus aureus in patients with cystic fibrosis. Motif Bio plc was incorporated in 2014 and is based in New York, New York.
Read More
MOTIF BIO PLC/S logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.29 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:MTFB
CUSIPN/A
Phone212-210-6248

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value($0.60) per share

Profitability

Miscellaneous

Employees7
Market Cap$1.56 million
Next Earnings DateN/A
OptionableNot Optionable

Receive MTFB News and Ratings via Email

Sign-up to receive the latest news and ratings for MTFB and its competitors with MarketBeat's FREE daily newsletter.

MOTIF BIO PLC/S (NASDAQ:MTFB) Frequently Asked Questions

How has MOTIF BIO PLC/S's stock been impacted by COVID-19 (Coronavirus)?

MOTIF BIO PLC/S's stock was trading at $0.1050 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, MTFB shares have increased by 0.0% and is now trading at $0.1050. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of MOTIF BIO PLC/S?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MOTIF BIO PLC/S in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for MOTIF BIO PLC/S.

What price target have analysts set for MTFB?

1 Wall Street analysts have issued 1-year price objectives for MOTIF BIO PLC/S's shares. Their forecasts range from $5.00 to $5.00. On average, they anticipate MOTIF BIO PLC/S's stock price to reach $5.00 in the next year. This suggests a possible upside of 4,661.9% from the stock's current price. View analysts' price targets for MOTIF BIO PLC/S.

Has MOTIF BIO PLC/S been receiving favorable news coverage?

News coverage about MTFB stock has been trending extremely negative on Monday, according to InfoTrie Sentiment. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. MOTIF BIO PLC/S earned a news sentiment score of -5.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news aboutMOTIF BIO PLC/S.

Who are some of MOTIF BIO PLC/S's key competitors?

What other stocks do shareholders of MOTIF BIO PLC/S own?

Who are MOTIF BIO PLC/S's key executives?

MOTIF BIO PLC/S's management team includes the following people:
  • Dr. Graham George Lumsden, CEO & Exec. Director (Age 59)
  • Mr. Jonathan E. Gold, CFO & Exec. Director (Age 46)
  • Dr. David B. Huang, Chief Medical Officer (Age 44)
  • Mr. Robert Dickey IV, Advisor (Age 63)
  • Laurie Doyle, Head of Investor Relations & Corp. Communications

When did MOTIF BIO PLC/S IPO?

(MTFB) raised $17 million in an initial public offering on Friday, November 18th 2016. The company issued 2,400,000 shares at $6.98 per share. H.C. Wainwright & Co. served as the underwriter for the IPO.

What is MOTIF BIO PLC/S's stock symbol?

MOTIF BIO PLC/S trades on the NASDAQ under the ticker symbol "MTFB."

How do I buy shares of MOTIF BIO PLC/S?

Shares of MTFB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is MOTIF BIO PLC/S's stock price today?

One share of MTFB stock can currently be purchased for approximately $0.11.

How big of a company is MOTIF BIO PLC/S?

MOTIF BIO PLC/S has a market capitalization of $1.56 million. MOTIF BIO PLC/S employs 7 workers across the globe.

What is MOTIF BIO PLC/S's official website?

The official website for MOTIF BIO PLC/S is www.motifbio.com.

How can I contact MOTIF BIO PLC/S?

MOTIF BIO PLC/S's mailing address is 201 TEMPLE CHAMBERS 3-7 TEMPLE AVENUE, LONDON X0, EC4Y0DT. The company can be reached via phone at 212-210-6248 or via email at [email protected]

This page was last updated on 6/1/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.